XML 16 R14.htm IDEA: XBRL DOCUMENT v2.3.0.15
RESTATEMENT
9 Months Ended
Sep. 30, 2011
RESTATEMENT [Text Block]

NOTE 9- RESTATEMENT

 

On August 2, 2011, management of the Company concluded that the financial statements for the year ended December 31, 2010, contained an error relating to the recording of financing-related expenses incurred during 2010.   Financing expenses in the amount of $466,281 were expensed in total during the year ended December 31, 2010.   Management subsequently determined that the financing expenses should have been recorded as a discount to the associated note payable and amortized over the term of the related note.  As a result, the previously issued financial statements for the year ended December 31, 2010 have been restated to reflect the appropriate accounting.  Of the $466,281 adjustment at December 31, 2011, financing costs of $416,281 and related debt discount of $87,434 are attributable to the three and nine month periods ending September 30, 2010.  This adjustment at September 30, 2010, results in a net reduction in loss of $328,847, reducing the net loss for the three and nine month periods to $1,535,868 and $2,153,046, respectively.  

The effect on the previously issued financial statements for the year ended December 31, 2010, is summarized as follows:

 

             

 

 

As

 

 

 

 

 

 

Initially

Reported

 

 

 

As

Restated at

 

 

December 31,

2010

 

Correcting

Entries

 

December 31,

2010

 

 

 

 

 

 

 

Total Assets

$

 1,871,558

$

 -

$

 1,871,558

    Current Liabilities

$

 2,385,346

$

 (374,236)

$

 2,011,110

    Long Term Liabilities

 

 496,189

 

 -

 

 496,189

    Equity

 

 (1,009,977)

 

 374,236

 

 (635,741)

Total Liabilities and Shareholder’s Equity

$

 1,871,558

$

 -

$

 1,871,558

 

 

 

 

 

 

 

For the year ended December 31, 2010

 

 

 

 

 

 

Operating Loss

$

 (2,304,272)

$

 -

$

 (2,304,272)

Other Income (Expense)

 

 (929,574)

 

 374,236

 

 (555,338)

Net Loss

$

 (3,233,846)

$

 374,236

$

 (2,859,610)

 

 

 

 

 

 

 

Basic and Diluted Loss Per Share

$

 (0.44)

$

 0.05

$

 (0.39)